• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      US pharma firm opens R & D Unit in Bangalore

      Posted AtNew Kerala.com

      US-based SPI Pharma has launched its development centre in the country to come out with innovative drug delivery systems.

      With an initial investment of Rs four crore, the India centre is expected to cater to the needs of the Asia Pacific Region.

      "We thought of an extension outside US and it was decided that India was the most appropriate place and hence was chosen. There are several advantages of setting the development centre here. First is that it has given us the opportunity to grow and second is that we have got the opportunity to tap the vast talent of highly qualified and potentially brilliant brains of India," says John Burrow, CEO, SPI Pharma.

      The 16,000 sq ft facility is a full-fledged drug development and testing centre that would cater to the needs of pharmaceutical manufacturers. The company is also speculating investment in Intellectual Property, to tap the tremendous potential available in the country.

      "To be able to have access to patient friendly technology India has for the first time welcomed this kind of an idea. We looked at the efficacy and at the same time cheap production of drugs when we decided to setup this centre. The medicine for Cough and cold is already in the market and PCM will be available in 2006 in India. The focus of the centre would be on excipients, antacid actives, drug delivery systems and drug development services," says Sarath Chander, Vice President, Global Marketing and Commercial Development.

      The company is currently working with Cipla, Novartis, Pfizer and Dr Reddy's in India and is in discussion with Biocon and Matrix.

      With India fast becoming a scientific powerhouse in the global pharma market, the new facility is being looked at as a significant step for the company's operations in the country.

      With the centre, SPI Pharma would now be in a position to speed up customised projects. SPI's strategy in India is to develop and test finished drugs using its proprietary drug delivery technologies as well as those acquired through strategic partners.

      December 13, 2005


       

      Share this Article!

    Back to top^